Thursday, Jun 1, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Business | Msn Obtains Us Fda Nod For Asenapine Sublingual Tablets

MSN gets US FDA nod for Asenapine Sublingual tablets

Asenapine is indicated for the treatment of patients suffering from Schizophrenia and Bipolar disorder

By Telangana Today
Updated On - 06:13 PM, Sun - 7 March 21
MSN gets US FDA nod for Asenapine Sublingual tablets
whatsapp facebook twitter telegram

Hyderabad: MSN Group (MSN) received final approval for its abbreviated new drug application (ANDA) for Asenapine Sublingual Tablets, in 5 mg strength, a generic for Saphris, with the US Food and Drug Administration. Asenapine is indicated for the treatment of patients suffering from Schizophrenia and Bipolar disorder.

MSN previously received final approval for 2.5mg and 10mg strengths of the same product. The product will be launched by its marketing partner Breckenridge Pharmaceutical.

As per industry sales data, Asenapine had annual sales of $239 million during the twelve months ending September 2020.

MSN has over 100 ANDAs and 375 US Active Drug Master Files (DMFs). MSN has nine active pharmaceutical ingredient and five finished dosage facilities in Hyderabad including one in the US.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • ANDA
  • Asenapine
  • Asenapine Sublingual Tablets
  • MSN

Related News

  • MSN Group provides food delivery vans for Akshaya Patra Foundation

    MSN Group provides food delivery vans for Akshaya Patra Foundation

  • Dr Reddy’s cuts price of heart drug, MSN launches breast cancer tablets

    Dr Reddy’s cuts price of heart drug, MSN launches breast cancer tablets

  • Three Hyderabad firms to make generic version of Pfizer’s Covid drug

    Three Hyderabad firms to make generic version of Pfizer’s Covid drug

  • MSN set to launch molnupiravir generic drug for Covid-19 treatment

    MSN set to launch molnupiravir generic drug for Covid-19 treatment

  • MSN Group launches anti-epileptic drug for infants

    MSN Group launches anti-epileptic drug for infants

  • Sun Pharma settles patent dispute with US Celgene Corporation

    Sun Pharma settles patent dispute with US Celgene Corporation

Latest News

  • IAF trainer aircraft crashes in Karnataka, pilots safe

    7 mins ago
  • Weekend guide: Here’s what’s going on in the city

    16 mins ago
  • Delhi excise policy scam case: Accused Sarath Chandra Reddy turns approver

    13 mins ago
  • These brands are turning waste into cool home décor 

    34 mins ago
  • WhatsApp Beta testing new feature to discover channels with filters

    35 mins ago
  • Royal wedding unfolds in Jordan: Prince William and Kate surprise guests

    50 mins ago
  • Alia Bhatt’s grandfather Narendranath Razdan passes away at 93

    1 hour ago
  • Karnataka: Indian Air Force’s trainer aircraft crashes, pilots eject safely

    1 hour ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam